Clinical Trials Browser

Phase 2 × Urologic Neoplasms × Bevacizumab × Clear all

NCT00019539 2024-03-04

Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell, Neoplasms, Urologic Neoplasms